(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 42099.80 | 47978.90 | -12.25 | 189799.50 | 190448.50 | -0.34 | 189799.50 | 190448.50 | -0.34 |
| Other Income | 1802.20 | 2933.70 | -38.57 | 11226.50 | 9847.20 | 14.01 | 11226.50 | 9847.20 | 14.01 |
| PBIDT | 7783.30 | 16120.80 | -51.72 | 55890.40 | 67631.60 | -17.36 | 55890.40 | 67631.60 | -17.36 |
| Interest | 67.40 | 34.90 | 93.12 | 193.00 | 151.10 | 27.73 | 193.00 | 151.10 | 27.73 |
| PBDT | 7715.90 | 19032.50 | -59.46 | 53253.70 | 70427.10 | -24.38 | 53253.70 | 70427.10 | -24.38 |
| Depreciation | 2491.10 | 1477.00 | 68.66 | 6894.30 | 5738.90 | 20.13 | 6894.30 | 5738.90 | 20.13 |
| PBT | 5224.80 | 17555.50 | -70.24 | 46359.40 | 64688.20 | -28.33 | 46359.40 | 64688.20 | -28.33 |
| TAX | 1378.40 | 2701.50 | -48.98 | 11207.60 | 13111.70 | -14.52 | 11207.60 | 13111.70 | -14.52 |
| Deferred Tax | 180.70 | -625.60 | -128.88 | 188.60 | -491.50 | -138.37 | 188.60 | -491.50 | -138.37 |
| PAT | 3846.40 | 14854.00 | -74.11 | 35151.80 | 51576.50 | -31.85 | 35151.80 | 51576.50 | -31.85 |
| Equity | 1615.60 | 1615.20 | 0.02 | 1615.60 | 1615.20 | 0.02 | 1615.60 | 1615.20 | 0.02 |
| PBIDTM(%) | 18.49 | 33.60 | -44.98 | 29.45 | 35.51 | -17.08 | 29.45 | 35.51 | -17.08 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1789.25 |
| Dr. Reddys Lab | 1274.20 |
| Cipla | 1387.50 |
| Zydus Lifesciences | 1088.05 |
| Lupin | 2264.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: